Skip Navigation LinksHome > April/June 2012 - Volume 23 - Issue 2 > Controversies in Acute Stroke Treatment
AACN Advanced Critical Care:
doi: 10.1097/NCI.0b013e31824fe1b6
Symposium the Challenge of Caring for Critically Ill Neuroscience Patients

Controversies in Acute Stroke Treatment

Brethour, Mary K. PhD, CRNP, ANVP; Nyström, Karin V. MSN, APRN, ANVP; Broughton, Sandra MSN, APRN-BC, CNRN, ANVP; Kiernan, Terri E. RN, MSN, ANP-BC, ANVP, CCRN, CNRN; Perez, Amy RN, MSN, CNRN, ANVP; Handler, Diane RN, MSN, ANVP; Swatzell, Victoria RN, MSN, ANP-C, ANVP; Yang, Joanna Jiehong RN, MS, RNFA, FNP-BC, ACNP-BC, ANVP; Starr, Michele PA-C, ANVP; Seagraves, Karen B. RN, MSN, ANP-BC, ANVP; Cudlip, Fern RN, MSN, FNP-BC, ANVP; Biby, Sharon RN, MSN, ANP-BC, GNP-BC, ANVP; Tocco, Susan RN, MSN, CNRN, CCNS, ANVP; Owens, Pauline RN, MSN, ANVP; Alexandrov, Anne W. RN, PhD, CCRN, ANVP

Section Editor(s): Blissitt, Patricia A. RN, PhD, CCRN, CNRN, CCNS, CCM, ACNS-BC; Symposium Editor

Continued Education
Collapse Box


The evidence base supporting the management of patients with acute stroke is evolving at a rapid rate, as new methods that aim to reduce disability and death from stroke are explored. Intravenous tissue plasminogen activator remains the only treatment shown in numerous studies to reduce disability 3 months after stroke with no increase in the risk of death and a relatively minor rate of symptomatic intracerebral hemorrhage complications. Despite these findings, health care providers have been slow to adopt this evidence-based treatment, which results in many patients experiencing disability caused by stroke. Numerous controversies exist related to the management of patients with acute stroke, including the use of tissue plasminogen activator, positioning and early mobility, blood pressure lowering in acute intracerebral hemorrhage, and even the use of innovative advanced practice nurse–led stroke treatment teams, with varying amounts of evidence available to provide direction. This article explores controversies associated with both approved and evolving treatments for ischemic and hemorrhagic stroke and makes recommendations for practice on the basis of the body of existing evidence, with an aim to improve the delivery of acute stroke treatment.

© 2012 American Association of Critical–Care Nurses


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.